GeneDx Holdings Corp.
WGS
37 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Oct 29 11:44 PM | Katherine Stueland | Proposed Sale | 2,154 | $66.60 | $143.5K | — | View → |
| Sep 17, 2024 | Sep 20 6:56 PM | OPKO HEALTH, INC. | Proposed Sale | 13,404 | $40.88 | $548.0K | — | View → |
| Sep 16, 2024 | Sep 16 10:54 PM | Kevin Feeley | Proposed Sale | 2,635 | $37.59 | $99.0K | — | View → |
| Sep 16, 2024 | Sep 16 10:54 PM | Katherine Stueland | Proposed Sale | 10,501 | $37.59 | $394.7K | — | View → |
| Sep 9, 2024 | Sep 10 1:03 AM | Kevin Feeley | Proposed Sale | 895 | $33.33 | $29.8K | — | View → |
| Sep 9, 2024 | Sep 10 1:03 AM | Katherine Stueland | Proposed Sale | 3,639 | $33.33 | $121.3K | — | View → |
| Sep 3, 2024 | Sep 4 1:35 AM | Kevin Feeley | Proposed Sale | 262 | $31.71 | $8.3K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | May 12 12:43 AM | Casdin Capital, LLCDirector, 10% Owner | Purchase | 500,000 | — | 500,000(I) | View → |
| Apr 29, 2026 | May 1 8:28 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 3,874 | — | 0(D) | View → |
| Apr 29, 2026 | May 1 8:24 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 754 | — | 0(D) | View → |
| Mar 26, 2026 | Mar 30 9:38 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 16,250 | — | 32,500(D) | View → |
| Mar 26, 2026 | Mar 30 9:30 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 80,000 | — | 160,000(D) | View → |
| Mar 16, 2026 | Mar 17 10:40 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 18,750 | — | 75,000(D) | View → |
| Mar 15, 2026 | Mar 17 10:40 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 11,921 | — | 35,763(D) | View → |
| Mar 16, 2026 | Mar 17 10:39 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 7,197 | — | 28,787(D) | View → |
| Mar 15, 2026 | Mar 17 10:39 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 3,815 | — | 11,446(D) | View → |
| Mar 9, 2026 | Mar 11 8:28 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 2,462 | — | 7,387(D) | View → |
| Mar 9, 2026 | Mar 11 8:26 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 6,546 | — | 19,640(D) | View → |
| Mar 3, 2026 | Mar 5 10:50 PM | Bryan DechairoChief Operating Officer | Grant/Award | 10,430 | — | 10,430(D) | View → |
| Mar 3, 2026 | Mar 5 10:49 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Grant/Award | 10,865 | — | 10,865(D) | View → |
| Mar 3, 2026 | Mar 5 10:46 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 40,418 | — | 40,418(D) | View → |
| Mar 1, 2026 | Mar 3 9:38 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 718 | — | 1,434(D) | View → |
| Feb 1, 2026 | Feb 4 12:30 AM | Bryan DechairoChief Operating Officer | Option Exercise | 9,374 | — | 28,123(D) | View → |
| Jan 29, 2026 | Feb 2 9:33 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 754 | — | 754(D) | View → |
| Jan 29, 2026 | Feb 2 9:30 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 3,874 | — | 3,874(D) | View → |
← Previous
Page 2 of 2